Published in BMC Genomics on July 06, 2007
The complete genome sequence of Cupriavidus metallidurans strain CH34, a master survivalist in harsh and anthropogenic environments. PLoS One (2010) 1.78
Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol (2014) 1.40
Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. J Bacteriol (2008) 1.03
Transcriptional profiling of the iron starvation response in Bordetella pertussis provides new insights into siderophore utilization and virulence gene expression. J Bacteriol (2011) 1.02
Contribution of Bordetella bronchiseptica filamentous hemagglutinin and pertactin to respiratory disease in swine. Infect Immun (2009) 1.01
Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infect Immun (2009) 0.97
BpsR modulates Bordetella biofilm formation by negatively regulating the expression of the Bps polysaccharide. J Bacteriol (2011) 0.88
Phenotypic modulation of the virulent Bvg phase is not required for pathogenesis and transmission of Bordetella bronchiseptica in swine. Infect Immun (2011) 0.88
A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo. PLoS One (2012) 0.85
Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica. Infect Immun (2009) 0.84
Microarray and functional analysis of growth phase-dependent gene regulation in Bordetella bronchiseptica. Infect Immun (2009) 0.83
The Bordetella bronchiseptica type III secretion system is required for persistence and disease severity but not transmission in swine. Infect Immun (2013) 0.83
Comparative analyses of a cystic fibrosis isolate of Bordetella bronchiseptica reveal differences in important pathogenic phenotypes. Infect Immun (2014) 0.82
Transcriptome profiling reveals stage-specific production and requirement of flagella during biofilm development in Bordetella bronchiseptica. PLoS One (2012) 0.80
Identification of a CO2 responsive regulon in Bordetella. PLoS One (2012) 0.77
Modulation of pertussis and adenylate cyclase toxins by sigma factor RpoE in Bordetella pertussis. Infect Immun (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
TM4: a free, open-source system for microarray data management and analysis. Biotechniques (2003) 38.02
Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol (2001) 14.57
DNA arrays for analysis of gene expression. Methods Enzymol (1999) 12.50
Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet (2003) 9.13
A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol (1970) 8.89
Genetic analysis of phase change in Bordetella pertussis. Infect Immun (1984) 5.03
Antigenic modulation of Bordetella pertussis. J Hyg (Lond) (1960) 4.61
Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray. Genome Biol (2003) 4.24
ATP-binding cassette transporters in bacteria. Annu Rev Biochem (2004) 3.88
Ectopic expression of the flagellar regulon alters development of the Bordetella-host interaction. Cell (1995) 3.64
BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect Immun (1994) 3.44
Phosphorelay control of virulence gene expression in Bordetella. Trends Microbiol (2003) 2.60
Evolutionary dynamics of prokaryotic transcriptional regulatory networks. J Mol Biol (2006) 2.44
The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica. J Bacteriol (1992) 2.33
A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg-regulated antigens. Mol Microbiol (1997) 2.01
Flagellin gene transcription in Bordetella bronchiseptica is regulated by the BvgAS virulence control system. J Bacteriol (1993) 1.94
Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol (2006) 1.70
Technology for microarray analysis of gene expression. Curr Opin Biotechnol (1998) 1.58
Subtilisin-like autotransporter serves as maturation protease in a bacterial secretion pathway. EMBO J (2001) 1.48
Neither the Bvg- phase nor the vrg6 locus of Bordetella pertussis is required for respiratory infection in mice. Infect Immun (1998) 1.41
The bordetellae: lessons from genomics. Nat Rev Microbiol (2004) 1.37
Growth and survival of Bordetella bronchiseptica in natural waters and in buffered saline without added nutrients. Appl Environ Microbiol (1991) 1.33
The roles of mucD and alginate in the virulence of Pseudomonas aeruginosa in plants, nematodes and mice. Mol Microbiol (2001) 1.22
Contribution of regulation by the bvg locus to respiratory infection of mice by Bordetella pertussis. Infect Immun (1998) 1.19
BopC is a novel type III effector secreted by Bordetella bronchiseptica and has a critical role in type III-dependent necrotic cell death. J Biol Chem (2006) 1.14
DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis. Infect Immun (2002) 1.14
bvg Repression of alcaligin synthesis in Bordetella bronchiseptica is associated with phylogenetic lineage. J Bacteriol (1995) 1.11
Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis. Mol Genet Genomics (2003) 1.06
Molecular analysis of the bvg-repressed urease of Bordetella bronchiseptica. Microb Pathog (1996) 1.02
Differential regulation of the Bordetella bipA gene: distinct roles for different BvgA binding sites. J Bacteriol (2002) 0.97
Characterization of the filamentous hemagglutinin-like protein FhaS in Bordetella bronchiseptica. Infect Immun (2005) 0.95